ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.99
BATS BZX Real-Time Price
As of 1:00pm ET
 -0.27 / -0.69%
Today’s Change
15.64
Today|||52-Week Range
40.25
+22.80%
Year-to-Date

Today’s Trading

Previous close39.26
Today’s open39.00
Day’s range38.90 - 39.70
Volume591,161
Average volume (3 months)1,341,854
Market cap$3.9B
Dividend yield--
Data as of 12:47pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-14.14%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.45-1.41%
NBIXNeurocrine Bioscienc...-0.09-0.22%
SGENSeattle Genetics Inc-0.22-0.62%
RCPTReceptos Inc-1.51-1.07%
Data as of 1:00pm ET, 03/06/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account